Cannabis Law Report

JULY 29, 2021

This initial export to Austria marks Avicanna’s first commercial export of psychoactive THC Cannabis Extracts into the emerging European medicinal cannabis market. Initial shipment of THC extracts into the European Union. New progressive regulation on cannabis in Colombia.

Extraction 98

Extraction Supply Chain THC Research and Development 98

Veriheal

AUGUST 16, 2021

It is a sad day in America when private corporations like Amazon and the NFL are making bigger moves to support the public opinion of cannabis than the elected representatives in the US government. To put that in perspective financially, the cannabis industry is predicted to produce $24 billion in sales this year. That says a lot.

Therapy 104

Therapy Chronic Pain Research and Development Treatment 104

Cannabis Law Report

JUNE 5, 2019

The Pharmaceutical Organization, Department of Medical Affairs, signed a joint research on standard quality medical marijuana extracts for patients with chemo-allergic cancer, epilepsy, muscle contraction in patients with deteriorating nerve sheaths. Today (30 May) at 09.30

Pharmaceutical 40

Pharmaceutical Extraction Epilepsy Research and Development 40

MMJ Recs

APRIL 25, 2024

However, the production of medical cannabis involves a meticulous process to ensure quality, potency, and safety for patients. Medical Marijuana Cultivation Process: The medical marijuana cultivation process is foundational in ensuring the production of high-quality cannabis products.

Marijuana 52

Marijuana Cultivation Safety Trichome 52

Cannabis Law Report

JANUARY 10, 2022

Panacea”), a leading United States biotechnology company focused on developing new therapeutic, cultivation, extraction and isolation techniques for high value natural products such as psychedelic-containing lifeforms and cannabis. is a Canadian biotechnology company providing cannabis testing and research services.

Research and Development 52

Research and Development Supply Chain DEA Events 52

Cannabis Law Report

SEPTEMBER 14, 2021

The new Radicle Science-OBX alliance fills an unmet need for rigorous scientific research in the cannabis industry and sets a new gold standard for CBD and minor cannabinoid product development.

Extraction 52

Extraction Research and Development Clinical Trials CBD 52

Cannabis Law Report

APRIL 13, 2022

Delic Labs’ latest exemptions enable the Company to develop innovative analytical methods for psychedelic research. Last year, the lab also applied for a Dealer’s License with the intent of commercializing psilocybin research and associated intellectual property (IP) for medical and research purposes.

Research and Development 52

Research and Development Treatment Extraction Medicine 52

SpeedWeed

JULY 23, 2021

Denver is expanding Alzheimer’s research through the efforts of local company MedPharm. . The company plans to move forward with research efforts through a special Schedule I Researcher Licenses given specifically to the company by the Drug Enforcement Administration. Denver Company Moves Forward with Research License .

Clinical Trials 52

Clinical Trials Research and Development DEA Cannabinoids 52

Cannabis Law Report

JANUARY 19, 2022

Frankfurt : C4T, ISIN: CA39540L1085) (CSE: XCX) (“Greenrise Global”) a distributor of medical and CBD wellness cannabis products in Germany announces that its wholly-owned subsidiary, AMP Alternative Medical Products GmbH (“AMP”) and Little Green Pharma Ltd. HAMBURG, Germany and PERTH, Australia , Jan.

Extraction 52

Extraction Oil Research and Development Medicine 52

Cannabis Law Report

OCTOBER 6, 2021

The lab currently holds a 56 Research Exemption for chemistry analytics on psilocybin mushrooms. Additionally, the lab has applied for a Dealer’s License and intends to eventually commercialize its psilocybin research and associated intellectual property (IP) for medical and research purposes.

Research and Development 52

Research and Development Extraction Treatment Safety 52

MMJ Recs

MARCH 16, 2024

This burgeoning industry encompasses a wide range of activities, including cultivation, processing, distribution, and retail sales of medical cannabis products. Demographic shifts also play a role, with older adults increasingly turning to medical cannabis for pain management and symptom relief.

Supply Chain 105

Supply Chain Research and Development Marijuana Seed-To-Sale 105

Cannabis Law Report

AUGUST 18, 2021

British medical cannabis company Grow announced today that it has acquired a major medical cannabis production facility in Spain – a move which transforms Grow into an integrated cannabis production, R&D, and distribution company. million within an hour of the crowdfund opening publicly.

Supply Chain 105

Supply Chain Research and Development Agriculture Medicine 105

United Patients Group

JULY 7, 2023

Cannabis has been used for medicinal purposes for thousands of years, dating back to ancient civilizations in Asia, Africa, and the Americas. In recent years, there has been a growing interest in the use of medical cannabis to manage a variety of health conditions.

Chronic Pain 105

Chronic Pain Sleep Epilepsy Conditions 105

SpeedWeed

SEPTEMBER 4, 2021

The DEA published a new document in the Federal Register on September 2 requesting an increase in production for certain Schedule I and Schedule II substances so that it can initiate more research studies. . DEA firmly believes in supporting regulated research of schedule I controlled substances. Some states in the U.S.

DEA 52

DEA Research and Development Clinical Trials Extraction 52

Cannabis Law Report

AUGUST 3, 2021

Europe-based Kanabo Group Plc (LSE: KNB), the first medical cannabis company to IPO on London Stock Exchange , has signed a letter of intent to acquire Materia – a processor and distributor of medical cannabis and CBD products across Europe for an undisclosed amount.

Research and Development 105

Research and Development Extraction Consumption Patients 105

Cannabis Law Report

JULY 28, 2021

InnarisBio), to develop a novel sol-gel intranasal drug delivery technology to improve treatments for mental health disorders. The platform technology has been successfully utilized with both water soluble and insoluble compounds and extracts. A potential solution is direct nose-to-brain delivery.

Research and Development 98

Research and Development Programs Treatment Media 98

United Patients Group

APRIL 18, 2023

Introduction The medical cannabis industry is booming. However, there are still many myths about cannabis that persist despite being debunked by medical professionals and researchers alike. Myth: Cannabis is just a drug. Cannabis is a plant. Myth: Cannabis is a gateway to other drugs.

Research and Development 108

Research and Development Indica Treatment Conditions 108

Project CBD

MARCH 8, 2019

In recent years, the use of cannabis in veterinary medicine has gone from obscure concept to a mainstream issue. This explosion of interest in the use of cannabis and CBD for animals has led to the development of a multi-million dollar industry creating cannabis-based products for pets. Medical Cannabis in California.

Pets 215

Pets Legalization Hemp Extraction 215

Cannabis Law Report

NOVEMBER 22, 2019

MMJ International Holdings, the premier medical cannabis research company, announced that it has received DEA approval to ship THC and CBD from Canada. MMJ International Holdings is developing oral drug products from natural whole plant extract derivatives from the marijuana plant containing THC and CBD.

DEA 66

DEA Clinical Trials THC Research and Development 66

Cannabis Law Report

NOVEMBER 17, 2021

. (“ZYUS”), a Canadian-based life sciences company leading scientific research and development in phyto-therapeutics, announced today that the company has launched a new THC-dominant medical cannabinoid formulation, Zylem™ 20:1, for direct sales and distribution to registered medical patients across Canada.

Cannabinoids 52

Cannabinoids Patients Research and Development Extraction 52

Veriheal

DECEMBER 23, 2022

Cannabis prohibition is doing more than just creating a barricade between consumers and safe products. State Cannabis Contaminant Rules Vary Widely,” consumers have little choice but to purchase contaminated cannabis products. Researchers Inspected Cannabis Products for Contaminants. Led by Dr. Maxwell C.K.

Research and Development 77

Research and Development Agriculture Data Extraction 77

United Patients Group

FEBRUARY 6, 2023

Rick Simpson Oil, or RSO for short ( aka FECO – Full Extract Cannabis Oil ) is a cannabis-based oil developed by Canadian engineer and cannabis activist Rick Simpson. He allegedly was able to improve his health with RSO, a dark, sticky cannabis extract that can be used as a concentrate, edible, or topical.

Oil 52

Oil Extraction Concentrates Cannabinoids 52

United Patients Group

FEBRUARY 2, 2023

Using Cannabis For Health and Wellness Introduction Cannabis is a plant that has been used for thousands of years to treat many ailments. The first recorded use of cannabis was in 2737 BC, when Emperor Shen Nung documented its value as a medicine. But what exactly is cannabis? This is where cannabis comes in!

Blood Pressure 103

Blood Pressure Sleep Chronic Pain Digestion 103

Cannabis Law Report

JUNE 28, 2021

Pharmaceutical and Medical Cannabis Leaders Zambon GmbH and Adven GmbH will Drive Medical Cannabis Supporting Treatments for Neurological Therapies. The aim of the agreement is to make medical cannabis treatments available to patients, with an initial focus on neurological therapies. It is expected to be worth USD 2.1

Access 105

Access Research and Development Pharmaceutical Therapy 105

Cannabis Law Report

DECEMBER 15, 2021

Benjamin Manufacturing Company to provide cultivation and processing facilities for psilocybin-containing mushrooms for authorized research purposes. market for research purposes is absolutely key for us as we look to expand our business in 2022,” he adds. VANCOUVER, BC , Dec. 13, 2021 /CNW/ – Havn Life Sciences Inc.

Supply Chain 52

Supply Chain Research and Development DEA Pharmaceutical 52

Cannabis Law Report

FEBRUARY 1, 2022

New softgel capsule products further expand ZYUS’ medical cannabinoid offerings and provide patients a precise method for dosing. The two Zylem™ Softgel Capsule products each have their own unique colour to provide patients with an easy way to identify and distinguish between ZYUS softgel capsule formulations.

Cannabinoids 52

Cannabinoids Patients Research and Development Media 52

Greencamp

AUGUST 16, 2018

In this comprehensive guide, we are exploring the research on using cannabis for treating Amyotrophic lateral sclerosis (ALS)—a rare neuron disease that targets the motor neurons in the body. Both upper and lower motor neurons suffer severe damage in ALS patients. Exploring the available research on ALS and cannabinoids.

Strains 94

Strains Cannabinoids Research and Development Indica 94

MMJ Recs

MARCH 20, 2024

Maryland medical cannabis dispensary services Maryland’s medical cannabis dispensaries offer comprehensive services tailored to meet the needs of registered patients. Trained dispensary staff assist patients in product selection, dosage recommendations, and consumption methods, ensuring personalized care and guidance.

Dispensary 52

Dispensary Programs Access Patients 52

CannaMD

MAY 19, 2020

In a working draft of research prepared by Canadian scientists, study authors claim that their findings are “crucial for the future analysis of the effects of medical cannabis on COVID-19.” And then something interesting happened: Serendipitously, we noted that cannabis may also affect ACE2. COVID-19 Basics: ACE2.

Research and Development 131

Research and Development Sativa Marijuana Extraction 131

Project CBD

AUGUST 6, 2019

The 29th annual International Cannabinoid Research Society ( ICRS ) symposium, which convened last month in Bethesda, Maryland, featured new developments in CBD science that have far-reaching implications for many areas of medicine. But would tolerance develop with repeated dosing, thereby mitigating CBD ’s hypotensive effect?

CBD 218

CBD Blood Pressure Research and Development Cannabinoids 218

Veriheal

DECEMBER 8, 2023

kicks off while Florida looks ahead, California introduces employment protections for cannabis users, and the HSS’ cannabis report deadline approaches. Let’s dive into this week’s cannabis and psychedelic news. Last month , Ohio voters overwhelmingly passed Issue 2 officially legalizing recreational cannabis.

Recreational 101

Recreational Research and Development Epilepsy THC 101

The Cannigma

MARCH 2, 2021

Many US military veterans avoid speaking to a doctor before self-medicating with cannabis due to stigma and fear of consequences, potentially putting their health at risk, according to the findings of a new study. Reddit and the anonymity to talk about cannabis. Findings.”. ’ (Shutterstock).

Research and Development 143

Research and Development Treatment Chronic Pain Sleep 143

Veriheal

DECEMBER 28, 2021

Over the last few decades, the cannabis plant and its many components have been the focal point of research and stiff debate. D espite the Drug Enforcement Agency’s (DEA) announcement in May that it would soon start reviewing grower applications for research purposes, cannabis research continues to be tightly restricted.

Research and Development 93

Research and Development Chronic Pain Treatment Medicine 93

CannaMD

AUGUST 19, 2020

Can cannabis help treat the coronavirus? CannaMD takes a look at everything we know about cannabis and COVID-19 so far – separating science from spectacle, and highlighting key findings that might even surprise the most seasoned medical marijuana supporters. Coronavirus Basics. ” And their alternative strategy of choice?

Research and Development 141

Research and Development Marijuana Extraction Terpenes 141

Cannabis Law Report

JULY 29, 2021

OTTAWA, ON , July 29, 2021 /PRNewswire/ – Tetra Bio-Pharma Inc (“Tetra” or the Company”) (TSX: TBP) (OTCQB: TBPMF) (FRA: JAM1), a leader in cannabinoid-based drug discovery and development has announced that it filed a PCT patent application for Cannabis Plant Residue and Use Thereof, PCT Patent Application No.

Research and Development 105

Research and Development Clinical Trials Events Cannabinoids 105

Project CBD

AUGUST 6, 2019

The 29th annual International Cannabinoid Research Society ( ICRS ) symposium, which convened last month in Bethesda, Maryland, featured new developments in CBD science that have far-reaching implications for many areas of medicine. But would tolerance develop with repeated dosing, thereby mitigating CBD ’s hypotensive effect?

CBD 177

CBD Blood Pressure Research and Development Cannabinoids 177

Ezra Parzybok

JANUARY 20, 2020

Cannabis is a plant that holds promise for brain diseases, and we are going to explore that in this article. In this scenario, the beneficial health aspects of Cannabis become extremely important as an affordable and unconventional natural solution. The legal liberalization of Cannabis in recent times has only increased its popularity.

Patients 52

Patients Cannabinoids Research and Development CBD 52